Attitudes towards deprescribing in geriatric psychiatry: A survey among older psychiatric outpatients.
attitudes
deprescribing
geriatric psychiatry
older people
psychotropics
Journal
Basic & clinical pharmacology & toxicology
ISSN: 1742-7843
Titre abrégé: Basic Clin Pharmacol Toxicol
Pays: England
ID NLM: 101208422
Informations de publication
Date de publication:
12 Oct 2023
12 Oct 2023
Historique:
revised:
27
09
2023
received:
13
06
2023
accepted:
08
10
2023
pubmed:
12
10
2023
medline:
12
10
2023
entrez:
12
10
2023
Statut:
aheadofprint
Résumé
Understanding the patient perspective is a significant part of the deprescribing process. This study aimed to explore the attitudes of older patients with psychiatric disorders towards deprescribing. A total of 72 of psychiatric outpatients (68% women; median age 76 years) completed the validated Danish version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire. Patients used a median of eight medications (interquartile range 6-12), with 88%, 49% and 24% using antidepressants, antipsychotics and anxiolytics, respectively. Fifty-one percent of patients reported an intrinsic desire to stop one of their medications, while 92% would be willing to stop one on their physician's advice. Seventy-five percent of patients would be worried about missing out on future benefits following deprescribing and 37% had previous bad deprescribing experiences. Use of ≥8 regular medications was associated with more concerns about stopping medication and greater perceived burden of using medication, while use of antipsychotics was not associated with any differences in rPATD factor scores. It is crucial for health care professionals to be aware of patients' specific concerns and past experiences to promote a patient-centred deprescribing approach that takes into account the needs and preferences of older patients with psychiatric disorders.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Development and Research Fund
Informations de copyright
© 2023 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
Références
Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67(1):26-36. doi:10.1001/archgenpsychiatry.2009.175
Futtrup TB, Helnaes AK, Schultz H, Jensen M, Reuther LØ. Psychotropic medication in a randomly selected group of citizens receiving residential or home care. Dan Med J. 2014;61(12):A4965.
Nørgaard A, Jensen-Dahm C, Gasse C, Hansen ES, Waldemar G. Psychotropic polypharmacy in patients with dementia: prevalence and predictors. J Alzheimers Dis. 2017;56(2):707-716. doi:10.3233/JAD-160828
Gallego JA, Nielsen J, De Hert M, Kane JM, Correll CU. Safety and tolerability of antipsychotic polypharmacy. Expert Opin Drug Saf. 2012;11(4):527-542. doi:10.1517/14740338.2012.683523
Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging. 2012;29(1):15-30. doi:10.2165/11598420-000000000-00000
Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254-1268. doi:10.1111/bcp.12732
Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic diseases Management in Primary Care Settings: a systematic review of randomized controlled trials. J am Med Dir Assoc. 2018;19(11):923-935. doi:10.1016/j.jamda.2018.06.021
Van Leeuwen E, Anthierens S, van Driel ML, De Sutter A, De Beir R, Christiaens T. Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study. Acta Clin Belg. 2022;77(6):962-969. doi:10.1080/17843286.2021.2024384
Moth AE, Hølmkjaer P, Holm A, Rozing MP, Overbeck G. What makes Deprescription of psychotropic drugs in nursing home residents with dementia so challenging? A qualitative systematic review of barriers and facilitators. Drugs Aging. 2021;38(8):671-685. doi:10.1007/s40266-021-00875-1
Kelly D, Graffi J, Noonan M, et al. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study. BMJ Open. 2021;11(4):e046054. doi:10.1136/bmjopen-2020-046054
Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893. doi:10.1136/bmj.i2893
Eveleigh R, Speckens A, van Weel C, Oude Voshaar R, Lucassen P. Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators. Ther Adv Psychopharmacol. 2019;9:2045125319872344. doi:10.1177/2045125319872344
Dickinson R, Knapp P, House AO, et al. Long-term prescribing of antidepressants in the older population: a qualitative study. Br J Gen Pract. 2010;60(573):e144-e155. doi:10.3399/bjgp10X483913
Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised Patients' attitudes towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913-928. doi:10.1007/s40266-016-0410-1
Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharmacol. 2013;35(1):51-56. doi:10.1007/s11096-012-9704-5
Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer attitudes towards Deprescribing: a systematic review and meta-analysis. J Gerontol a Biol Sci Med Sci. 2022;77(5):1020-1034. doi:10.1093/gerona/glab222
Frankowski NEDM, Grootens KP, van der Stelt CA, Noort A, van Marum RJ. ‘You tell me, you are the doctor’; patients on long-term psychiatric residences about their medication. Tijdschr Voor Psychiatr. 2019;61(8):527-535.
Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140(6):734-739. doi:10.1176/ajp.140.6.734
Lundby C, Simonsen T, Ryg J, Søndergaard J, Pottegård A, Lauridsen HH. Translation, cross-cultural adaptation, and validation of the Danish version of the revised Patients' attitudes towards Deprescribing (rPATD) questionnaire: version for older people with limited life expectancy. Res Soc Adm Pharm RSAP. 2021;17(8):1444-1452. doi:10.1016/j.sapharm.2020.11.001
Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005;5(1):64. doi:10.1186/1472-6963-5-64
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24. doi:10.1080/08870449908407311
Lundby C, Glans P, Simonsen T, et al. Attitudes towards deprescribing: the perspectives of geriatric patients and nursing home residents. J am Geriatr Soc. 2021;69(6):1508-1518. doi:10.1111/jgs.17054
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi:10.1016/j.jbi.2008.08.010
Kent P, Lauridsen HH. Managing missing scores on the Roland Morris disability questionnaire. Spine. 2011;36(22):1878-1884. doi:10.1097/BRS.0b013e3181ffe53f
Tveden-Nyborg P, Bergmann TK, Jessen N, Simonsen U, Lykkesfeldt J. BCPT 2023 policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol Published online September 21, 2023:bcpt.13944. 133(4):391-396. doi:10.1111/bcpt.13944
Bergen N, Labonté R. “Everything is perfect, and we have no problems”: detecting and limiting social desirability bias in qualitative research. Qual Health Res. 2020;30(5):783-792. doi:10.1177/1049732319889354
Pereira A, Ribeiro O, Veríssimo M. Predictors of older patients' willingness to have medications deprescribed: a cross-sectional study. Basic Clin Pharmacol Toxicol Published online April 17, 2023. doi:10.1111/bcpt.13874
Edelman M, Jellema P, Hak E, Denig P, Blanker MH. Patients' attitudes towards Deprescribing alpha-blockers and their willingness to participate in a discontinuation trial. Drugs Aging. 2019;36(12):1133-1139. doi:10.1007/s40266-019-00712-6
Ikeji C, Williams A, Hennawi G, Brandt NJ. Patient and provider perspectives on Deprescribing proton pump inhibitors. J Gerontol Nurs. 2019;45(10):9-17. doi:10.3928/00989134-20190912-03
McCarthy C, Clyne B, Boland F, et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE study): a cluster randomised controlled trial. Scott I, ed. PLoS Med. 2022;19(1):e1003862. doi:10.1371/journal.pmed.1003862
McCarthy C, Pericin I, Smith SM, et al. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: process evaluation of the SPPiRE trial. Health Expect. 2022;25(6):3225-3237. doi:10.1111/hex.13630
Turner JP, Martin P, Zhang YZ, Tannenbaum C. Patients beliefs and attitudes towards deprescribing: can deprescribing success be predicted? Res Social Adm Pharm. 2020;16(4):599-604. doi:10.1016/j.sapharm.2019.07.007
Pétein C, Spinewine A, Laroche ML, Niquille A, Henrard S. Adaptation and validation of the revised Patients' attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists. Res Soc Adm Pharm RSAP Published online June 8. 2023;S1551-7411(23):00274-00277. doi:10.1016/j.sapharm.2023.05.010